Last update Nov. 27, 2021
Very Low Risk
Excretion into breast milk is insignificant. (Kafetzis 1981)
No adverse effects requiring medical attention have been observed in the majority of nursing infants whose mothers took this medication. (Benyamini 2005)
It is commonly prescribed for infants by Pediatricians.
It is considered medication compatible with breastfeeding by relevant authors and scientific societies. (LactMed, Hale, Briggs 2015, Schaefer2015, Rowe 2013, Amir 2011, Spencer 2008, Nahum 2006, Mahadevan 2006, Drobac 2005, Bar-Oz 2003, Chin 2000)
The possibility of transient restlessness, rash or gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account. (Benyamini 2005)
Eleventh WHO Model List of Essential Drugs: Compatible with breastfeeding. (WHO / UNICEF 2002)
We do not have alternatives for Αμοξυκιλλίνη + Κλαβουλανικό οξύ since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM